In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.
You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.
Episode Guests
Nicholas Pennings, DO, FOMA, Dipl. ABOM
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Resources Mentioned
Episode Description In this episode, the OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM and W. Allen Rader, MD, MFOMA review a...
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews OMA Vice President Lydia Alexander,...
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA)...